MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN. (Q40842781)

24 September 2017

MicroRNA 152 regulates hepatic glycogenesis by targeting PTEN. (English)

1 reference

24 September 2017

1 reference

Shuyue Wang

1

1 reference

24 September 2017

Lilin Wang

2

1 reference

24 September 2017

Lin Dou

3

1 reference

24 September 2017

Jun Guo

4

1 reference

24 September 2017

Weiwei Fang

5

1 reference

24 September 2017

Meng Li

6

1 reference

24 September 2017

Xiangyu Meng

7

1 reference

24 September 2017

Yong Man

8

1 reference

24 September 2017

Tao Shen

9

1 reference

24 September 2017

Xiuqing Huang

10

1 reference

24 September 2017

Jian Li

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

21 March 2016

1 reference

24 September 2017

1 reference

24 September 2017

283

1 reference

24 September 2017

1935-1946

1 reference

24 September 2017

10

1 reference

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

24 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

A pancreatic islet-specific microRNA regulates insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MicroRNAs 103 and 107 regulate insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

CHANGES IN microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MiR-301a mediates the effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by regulating PTEN expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Interleukin-6 depletion selectively improves hepatic insulin action in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

PTEN in liver diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Insulin hypersensitivity induced by hepatic PTEN gene ablation protects from murine endotoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

The role of PTEN in chronic growth hormone-induced hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

PTEN deletion in pancreatic α-cells protects against high-fat diet-induced hyperglucagonemia and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

The microRNA-148/152 family: multi-faceted players

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Role of miR-148a in hepatitis B associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

MiR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13713

21 January 2018

Identifiers

DOI

10.1111/FEBS.13713

1 reference

24 September 2017

1 reference